Identification of Novel Immunologic Checkpoint Gene Prognostic Markers for Ovarian Cancer

Ovarian cancer has a higher resistance to chemotherapy, displaying the highest mortality rate among gynecological cancers. Recently, immune checkpoint inhibitor therapy is an effective treatment for selected patients. However, a low response rate for immune checkpoint treatment was observed for ovar...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Xiao, Zhang, Xi, Li, Shuhong, Wang, Shuzhen, Sun, Hengzi, Yang, Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499758/
https://www.ncbi.nlm.nih.gov/pubmed/36157232
http://dx.doi.org/10.1155/2022/8570882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499758/
https://www.ncbi.nlm.nih.gov/pubmed/36157232
http://dx.doi.org/10.1155/2022/8570882

Ejemplares similares